Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 10, 2007. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility under the company's ShareReward Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The filing details the acquisition of Ordinary shares by four individuals on August 9, 2007, at a price of GBP 13.02 per share. The transactions occurred under the partnership and matching elements of the ShareReward Plan:
- Mr. J S Heslop: Acquired 10 shares (personal contribution) and 10 shares (company contribution).
- Mr. R Bondy: Acquired 10 shares (personal contribution) and 10 shares (company contribution).
- Mr. D Learmouth: Acquired 10 shares (personal contribution) and 10 shares (company contribution).
- Mr. A P Witty: Acquired 10 shares (personal contribution) and 10 shares (company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to Disclosure and Transparency Rules 3.1.4R(1)(a) and 3.1.4R(1)(b) regarding director share interests.
Investor Verification Points
- Verify the share price of GBP 13.02 against market data for August 9, 2007.
- Confirm the total number of shares acquired by each named director under the ShareReward Plan.
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the matching contribution structure.